Ascendis Pharma A (ASND) Enterprise Value (2012 - 2026)
Ascendis Pharma A (ASND) reported Enterprise Value of -$670.6 million for Q1 2026, down 23.1% on a YoY basis from -$872.0 million in Q1 2025, and up 33.95% sequentially from -$1.0 billion in Q4 2025.
Ascendis Pharma A (ASND) Enterprise Value (2012 - 2026) Analysis & Trends
Ascendis Pharma A (ASND) has 15 years of Enterprise Value data on file, last reported at -$670.6 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 23.1% year-over-year to -$670.6 million; the trailing twelve-month figure through Mar 2026 stood at -$670.6 million (down 23.1% YoY), and the FY2025 full-year result was -$1.0 billion, down 32.09% from the prior year.
- Enterprise Value grew to -$670.6 million in Q1 2026, from -$1.0 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$278.6 million in Q2 2024 to a low of -$1.0 billion in Q4 2025.
- A 5-year average of -$589.4 million and a median of -$559.2 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value surged 40.36% in 2023 and sank 100.74% in 2025, its largest moves.
- Tracing ASND's Enterprise Value over 5 years: stood at -$471.1 million in 2022, then increased by 10.43% to -$421.9 million in 2023, then sank by 79.86% to -$758.9 million in 2024, then tumbled by 33.79% to -$1.0 billion in 2025, then surged by 33.95% to -$670.6 million in 2026.
- Business Quant data shows ASND's Enterprise Value at -$670.6 million in Q1 2026, -$1.0 billion in Q4 2025, and -$630.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | -670.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -670.63 Mn |
| Dec 31, 2025 | -1.02 Bn |
| Sep 30, 2025 | -630.23 Mn |
| Jun 30, 2025 | -559.24 Mn |
| Mar 31, 2025 | -544.80 Mn |
| Dec 31, 2024 | -758.93 Mn |
| Sep 30, 2024 | -686.95 Mn |
| Jun 30, 2024 | -278.59 Mn |
| Mar 31, 2024 | -347.90 Mn |
| Dec 31, 2023 | -421.94 Mn |
| Sep 30, 2023 | -480.36 Mn |
| Jun 30, 2023 | -429.28 Mn |
| Mar 31, 2023 | -538.05 Mn |
| Dec 31, 2022 | -471.07 Mn |
| Sep 30, 2022 | -617.71 Mn |
| Jun 30, 2022 | -719.76 Mn |
| Mar 31, 2022 | -849.37 Mn |
| Dec 31, 2021 | -515.70 Mn |
| Sep 30, 2021 | -817.18 Mn |
| Jun 30, 2021 | -464.85 Mn |